Asubio Pharmaceuticals Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Asubio Pharmaceuticals General Information

Description

Provider of pharmaceuticall research and development. The company develops therapies and medicine for acute spinal injuries. It also focuses on chemical synthesis, biotechnology and peptide chemistry.

Contact Information

Website
www.asubio.com
Formerly Known As
Suntory Pharmaceutical
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Daiichi Sankyo US
Primary Office
  • 399 Thornall Street
  • Edison, NJ 08837
  • United States
+1 (201) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Asubio Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Asubio Pharmaceuticals‘s full profile, request access.

Request a free trial

Asubio Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Asubio Pharmaceuticals‘s full profile, request access.

Request a free trial